Catalyst Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Catalyst Capital Advisors's AMGN Position: Q2 2026 in Review
Catalyst Capital Advisors reduced its Amgen (AMGN) stake by 27% in Q2 2026, selling an estimated $18.8K and leaving 149 shares worth $54K. The position accounts for ﹤0.01% of the portfolio, ranked #288.
Catalyst Capital Advisors first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.1M in Q4 2018. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Catalyst Capital Advisors held 149 shares of Amgen worth $54K as of Q2 2026.
- Catalyst Capital Advisors sold 55 Amgen shares in Q2 2026, an estimated $18.8K.
- Amgen made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #288 holding.
- Catalyst Capital Advisors first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
- Catalyst Capital Advisors's Amgen position peaked at $22.1M in Q4 2018.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.